


Healthcare News Roundup: Neuro
HSMN NewsFeed - 8 Oct 2008
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
HSMN NewsFeed - 7 Oct 2008
Eden Spine Receives CE Mark for its Nonfusion Wellex(TM) Interspinous Process Medical Device
Eden Spine Receives CE Mark for its Nonfusion Wellex(TM) Interspinous Process Medical Device
HSMN NewsFeed - 2 Oct 2008
Orthofix International Receives 510(k) Approval For Next Generation Lumbar Fixation System
Orthofix International Receives 510(k) Approval For Next Generation Lumbar Fixation System
HSMN NewsFeed - 25 Sep 2008
Alphatec Spine Announces 510(k) Clearance for Its Novel Cervical Interbody Implant
Alphatec Spine Announces 510(k) Clearance for Its Novel Cervical Interbody Implant
HSMN NewsFeed - 25 Sep 2008
UCB Withdraws EU Marketing Authorisation Application for Lacosamide in Diabetic Neuropathic Pain
UCB Withdraws EU Marketing Authorisation Application for Lacosamide in Diabetic Neuropathic Pain
HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
HSMN NewsFeed - 23 Sep 2008
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
HSMN NewsFeed - 22 Sep 2008
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
HSMN NewsFeed - 22 Sep 2008
Integra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts
Integra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts
HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
HSMN NewsFeed - 18 Sep 2008
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
HSMN NewsFeed - 4 Sep 2008
Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
HSMN NewsFeed - 26 Aug 2008
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
HSMN NewsFeed - 20 Aug 2008
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
HSMN NewsFeed - 19 Aug 2008
NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
HSMN NewsFeed - 18 Aug 2008
Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US
Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US
